Interdigit and Njex proceed with European alliance
This article was originally published in Clinica
Executive Summary
Swiss company Interdigit (Nyon) is pushing ahead with plans to market implanting technology from Njex Medical Systems in Europe. The small, sterile Njex implants are well suited for controlled release and long-term targeted delivery implant treatments, says the company from Industry, California. The cost-effective procedures allowed by the technology are faster and simpler, and require "little or no surgical skill" in that they can implanted under outpatient conditions. The technology is expected to enhance treatment methods for a host of existing and emerging products, the companies say.